MedTrace Logo

Validation of a Clinical Screening Grid for Syndromic Schizophrenia

NCT02746510 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 129

Last updated 2025-03-06

No results posted yet for this study

Summary

Background:

Nowadays, despite a large number of studies about schizophrenia and genetics, clinical red flags for syndromic forms of schizophrenia remain poorly documented.

Conditions

Interventions

GENETIC

Array comparative genomic hybridization

For each of the 150 patients deoxyribose nucleic acid (DNA) exactracted from a jugal mucosae sample will be analysed by the cytogeneticist and a CGH-a will be performed.

Sponsors & Collaborators

  • Hospices Civils de Lyon

    collaborator OTHER

  • Hôpital le Vinatier

    lead OTHER

Principal Investigators

  • POISSON Alice, PH · Centre Hospitalier le Vinatier

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2023-02-28
Completion
2023-12-20

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02746510 on ClinicalTrials.gov